Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (222) 222
etv6-ntrk3 gene fusion (193) 193
index medicus (169) 169
pathology (130) 130
female (116) 116
oncology (97) 97
male (93) 93
tumors (88) 88
cancer (86) 86
etv6-ntrk3 (73) 73
immunohistochemistry (68) 68
oncogene proteins, fusion - genetics (68) 68
adult (67) 67
expression (57) 57
middle aged (56) 56
congenital fibrosarcoma (53) 53
diagnosis (50) 50
breast cancer (49) 49
carcinoma (47) 47
surgery (45) 45
pediatrics (42) 42
child (40) 40
in situ hybridization, fluorescence (40) 40
animals (39) 39
aged (37) 37
gene fusion (37) 37
infant (36) 36
infantile fibrosarcoma (36) 36
translocation, genetic (36) 36
mutation (35) 35
diagnosis, differential (34) 34
fibrosarcoma (34) 34
genetic aspects (34) 34
infant, newborn (34) 34
mesoblastic nephroma (34) 34
adolescent (33) 33
salivary gland neoplasms - pathology (33) 33
biomarkers, tumor - genetics (32) 32
repressor proteins - genetics (32) 32
chemotherapy (31) 31
reverse transcriptase polymerase chain reaction (31) 31
mammary analogue secretory carcinoma (30) 30
young adult (30) 30
cell biology (29) 29
salivary gland neoplasms - genetics (29) 29
analysis (28) 28
biomarkers, tumor - analysis (28) 28
carcinoma - pathology (28) 28
prognosis (28) 28
receptor, trkc - genetics (28) 28
research (28) 28
translocation (27) 27
breast neoplasms - pathology (26) 26
congenital mesoblastic nephroma (26) 26
in-situ hybridization (26) 26
child, preschool (25) 25
children (25) 25
fibrosarcoma - congenital (24) 24
sarcoma (24) 24
secretory carcinoma (24) 24
fibrosarcoma - genetics (23) 23
health aspects (23) 23
proto-oncogene proteins c-ets - genetics (23) 23
breast neoplasms - genetics (22) 22
carcinoma - genetics (22) 22
fibrosarcoma - diagnosis (22) 22
gene rearrangement (22) 22
leukemia (22) 22
mice (22) 22
genes (21) 21
hematology (21) 21
protein-tyrosine kinase (21) 21
salivary gland (21) 21
analog secretory carcinoma (20) 20
article (20) 20
etv6-ntrk3 fusion gene (20) 20
fibrosarcoma - pathology (19) 19
genetics & heredity (19) 19
breast (18) 18
care and treatment (18) 18
etv6 (18) 18
fusion (18) 18
medicine & public health (18) 18
metastasis (18) 18
acute lymphoblastic-leukemia (17) 17
biochemistry & molecular biology (17) 17
biopsy (17) 17
rearrangements (17) 17
salivary gland neoplasms - diagnosis (17) 17
acinic cell carcinoma (16) 16
acinic cell-carcinoma (16) 16
cell line, tumor (16) 16
kinases (16) 16
mammary analog secretory carcinoma (16) 16
mammary analogue secretory carcinoma - pathology (16) 16
proteins (16) 16
proto-oncogene proteins c-ets (16) 16
treatment outcome (16) 16
biomarkers, tumor - metabolism (15) 15
dna-binding proteins - genetics (15) 15
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Mammary Analogue Secretory Carcinoma of Salivary Glands: Molecular Analysis of 25 ETV6 Gene Rearranged Tumors With Lack of Detection of Classical ETV6-NTRK3 Fusion Transcript by Standard RT-PCR: Report of 4 Cases Harboring ETV6-X Gene Fusion
by Skálová, Alena and Vanecek, Tomas and Simpson, Roderick H.W and Laco, Jan and Majewska, Hanna and Baneckova, Martina and Steiner, Petr and Michal, Michal
The American Journal of Surgical Pathology, ISSN 0147-5185, 01/2016, Volume 40, Issue 1, pp. 3 - 13
ETV6 gene abnormalities are well described in tumor pathology. Many fusion partners of ETV6 have been reported in a variety of epithelial and hematological... 
REARRANGEMENT | SURGERY | TRANSLOCATION | ENTITY | ETV6-NTRK3 GENE FUSION | SARCOMA | MARKERS | CONGENITAL FIBROSARCOMA | MAMMAGLOBIN | LEUKEMIA | PATHOLOGY | EXPRESSION | Immunohistochemistry | Predictive Value of Tests | Prognosis | Proto-Oncogene Proteins c-ets - genetics | Salivary Gland Neoplasms - genetics | Humans | Mammary Analogue Secretory Carcinoma - pathology | Middle Aged | Male | Mammary Analogue Secretory Carcinoma - genetics | Young Adult | Molecular Diagnostic Techniques | Adult | Female | Registries | Mammary Analogue Secretory Carcinoma - chemistry | Genetic Predisposition to Disease | Mammary Analogue Secretory Carcinoma - therapy | Repressor Proteins - genetics | Gene Fusion | In Situ Hybridization, Fluorescence | Reverse Transcriptase Polymerase Chain Reaction | Salivary Gland Neoplasms - chemistry | Oncogene Proteins, Fusion - genetics | Gene Rearrangement | Salivary Gland Neoplasms - therapy | Adolescent | Aged | Biomarkers, Tumor - genetics | Salivary Gland Neoplasms - pathology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Mammary analogue secretory carcinoma of salivary glands, containing the etv6-ntrk3 fusion gene: A hitherto undescribed salivary gland tumor entity
by Skálová, Alena and Vanecek, Tomas and Sima, Radek and Laco, Jan and Weinreb, Ilan and Perez-Ordonez, Bayardo and Starek, Ivo and Geierova, Marie and Simpson, Roderrick Hw and Passador-Santos, Fabricio and Ryska, Ales and Leivo, Ilmo and Kinkor, Zdenek and Michal, Michal
American Journal of Surgical Pathology, ISSN 0147-5185, 2010, Volume 34, Issue 5, pp. 599 - 608
We present a series of 16 salivary gland tumors with histomorphologic and immunohistochemical features reminiscent of secretory carcinoma of the breast. This... 
Molecular pathology | Salivary gland | Acinic cell carcinoma | Secretory carcinoma | ETV6-NTRK3 translocation | Mammary type | SYNOVIAL SARCOMA | SURGERY | STAT 5A EXPRESSION | BREAST-CARCINOMA | SCLEROSING POLYCYSTIC ADENOSIS | EPITHELIAL-MYOEPITHELIAL CARCINOMA | CONGENITAL FIBROSARCOMA | HYBRIDIZATION | PATHOLOGY | secretory carcinoma | salivary gland | mammary type | acinic cell carcinoma | DIFFERENTIATION | molecular pathology | ACINIC CELL-CARCINOMA | IN-SITU | Immunohistochemistry | Translocation, Genetic | Oncogene Proteins, Fusion - metabolism | Salivary Gland Neoplasms - genetics | Humans | Middle Aged | Male | Neoplasms, Multiple Primary | Salivary Glands - surgery | Cystadenocarcinoma - metabolism | Young Adult | RNA, Neoplasm - analysis | Salivary Gland Neoplasms - metabolism | Biomarkers, Tumor - metabolism | Adult | Female | In Situ Hybridization, Fluorescence | Treatment Outcome | Combined Modality Therapy | Reverse Transcriptase Polymerase Chain Reaction | Cystadenocarcinoma - pathology | Cystadenocarcinoma - genetics | Oncogene Proteins, Fusion - genetics | Chromosomes, Human, Pair 15 | Gene Rearrangement | Aged | Chromosomes, Human, Pair 12 | Salivary Gland Neoplasms - pathology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Transcriptome sequencing identifies ETV6–NTRK3 as a gene fusion involved in GIST
by Brenca, Monica and Rossi, Sabrina and Polano, Maurizio and Gasparotto, Daniela and Zanatta, Lucia and Racanelli, Dominga and Valori, Laura and Lamon, Stefano and Dei Tos, Angelo Paolo and Maestro, Roberta
The Journal of Pathology, ISSN 0022-3417, 03/2016, Volume 238, Issue 4, pp. 543 - 549
Gastrointestinal stromal tumours ( GISTs ) are the most common mesenchymal neoplasms of the gastrointestinal tract. The vast majority of GISTs are driven by... 
fusion genes | chimera | ETV6–NTRK3 | GIST | transcriptome sequencing | ETV6-NTRK3 chimera | TRANSFORMATION | PDGFRA | RECEPTOR | PATHOLOGY | CANCER | INACTIVATION | ONCOLOGY | REQUIRES | LEUKEMIA | GASTROINTESTINAL STROMAL TUMORS | EXPRESSION | FIBROSARCOMA | Gastrointestinal Neoplasms - genetics | Proto-Oncogene Proteins c-ets - genetics | Humans | Middle Aged | Repressor Proteins - genetics | Exons - genetics | Male | Transcriptome - genetics | Mutation - genetics | Gastrointestinal Neoplasms - pathology | Gene Fusion - genetics | Receptor, trkC - genetics | Receptor, Platelet-Derived Growth Factor alpha - genetics | Aged, 80 and over | Cell Line, Tumor | Adult | Female | Aged | Gastrointestinal Stromal Tumors - genetics | Platelet-derived growth factor | Analysis | Genes | Gastrointestinal system | Stem cells
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Mammary Analogue Secretory Carcinoma of Salivary Glands With High-grade Transformation: Report of 3 Cases With the ETV6-NTRK3 Gene Fusion and Analysis of TP53, β-Catenin, EGFR, and CCND1 Genes
by Skálová, Alena and Vanecek, Tomas and Majewska, Hanna and Laco, Jan and Grossmann, Petr and Simpson, Roderick H W and Hauer, Lukas and Andrle, Pavel and Hosticka, Lubor and Branžovský, Jindrich and Michal, Michal
The American Journal of Surgical Pathology, ISSN 0147-5185, 01/2014, Volume 38, Issue 1, pp. 23 - 33
Mammary analogue secretory carcinoma of salivary gland origin (MASC) is a recently described tumor resembling secretory carcinoma of the breast characterized... 
fusion | salivary gland | mammary analogue secretory carcinoma | ETV6-NTRK3 | high-grade transformation | MASC | SURGERY | PAROTID-GLAND | DEDIFFERENTIATION | PATHOLOGY | LUNG-CANCER | ETV6-NTRK3 GENE FUSION | RECEPTOR GENE | ADENOID CYSTIC CARCINOMA | DIFFERENTIATION | LEUKEMIA | ACINIC CELL-CARCINOMA | EXPRESSION | Immunohistochemistry | Receptor, Epidermal Growth Factor - genetics | Prognosis | beta Catenin - analysis | Humans | Middle Aged | Male | Tumor Suppressor Protein p53 - genetics | Carcinoma - chemistry | Cyclin D1 - analysis | Neoplasm Grading | Time Factors | Cell Transformation, Neoplastic - genetics | DNA Mutational Analysis | Fatal Outcome | Parotid Neoplasms - chemistry | Parotid Neoplasms - therapy | Carcinoma - secondary | Biomarkers, Tumor - analysis | Receptor, Epidermal Growth Factor - analysis | beta Catenin - genetics | Cyclin D1 - genetics | Biopsy | Oncogene Proteins, Fusion - genetics | Parotid Neoplasms - pathology | Carcinoma - genetics | Carcinoma - therapy | Aged | Biomarkers, Tumor - genetics | Mutation | Cell Transformation, Neoplastic - pathology | Parotid Neoplasms - genetics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Secretory Breast Carcinoma: A Histopathologic and Genomic Spectrum Characterized by a Joint Specific ETV6-NTRK3 Gene Fusion
by Del Castillo, Marie and Chibon, Frédéric and Arnould, Laurent and Croce, Sabrina and Ribeiro, Agnès and Perot, Gaëlle and Hostein, Isabelle and Geha, Sameh and Bozon, Catherine and Garnier, Agnès and Lae, Marick and Vincent-Salomon, Anne and MacGrogan, Gaëtan
The American Journal of Surgical Pathology, ISSN 0147-5185, 11/2015, Volume 39, Issue 11, pp. 1458 - 1467
Secretory breast carcinoma (SBC) is a rare breast carcinoma with distinctive morphologic features and a recurrent specific chromosomal translocation... 
Fluorescent in situ hybridization | Comparative genomic hybridization | ETV6-NTRK3 | Secretory breast carcinoma | Triple-negative breast carcinoma | SURGERY | fluorescent in situ hybridization | secretory breast carcinoma | CONGENITAL FIBROSARCOMA | PATHOLOGY | comparative genomic hybridization | triple-negative breast carcinoma | CANCER | MESOBLASTIC NEPHROMA | ETV6 | ETV6-NTRK3 GENE FUSION | EXPRESSION | Gene Duplication | Immunohistochemistry | Mitosis | Humans | Middle Aged | Carcinoma - chemistry | Necrosis | Breast Neoplasms - therapy | Breast Neoplasms - chemistry | Neoplasm Grading | Adult | Female | Carcinoma - pathology | France | Breast Neoplasms - classification | Genetic Predisposition to Disease | Biomarkers, Tumor - analysis | Gene Fusion | In Situ Hybridization, Fluorescence | Treatment Outcome | Gene Dosage | Reverse Transcriptase Polymerase Chain Reaction | Phenotype | Breast Neoplasms - genetics | Comparative Genomic Hybridization | Biopsy | Breast Neoplasms - pathology | Oncogene Proteins, Fusion - genetics | Gene Rearrangement | Adolescent | Carcinoma - genetics | Carcinoma - therapy | Biomarkers, Tumor - genetics | Carcinoma - classification
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum
by Laé, Marick and Fréneaux, Paul and Sastre-Garau, Xavier and Chouchane, Olfa and Sigal-Zafrani, Brigitte and Vincent-Salomon, Anne
Modern Pathology, ISSN 0893-3952, 02/2009, Volume 22, Issue 2, pp. 291 - 298
Secretory breast carcinomas (< 0.15% of breast tumors) are associated with a characteristic morphology and a favorable prognosis. Remarkably, this entity is... 
Translocation | Breast | Basal cytokeratins | ETV6-NTRK3 | Secretory breast carcinoma | Basal-like carcinoma | basal-like carcinoma | translocation | PHENOTYPE | CONGENITAL FIBROSARCOMA | PATHOLOGY | basal cytokeratins | CANCER | TUMORS | CHEMOTHERAPY | breast | EXPRESSION | IN-SITU | Breast Neoplasms - classification | Immunohistochemistry | Translocation, Genetic | Biomarkers, Tumor - analysis | Neoplasm Invasiveness | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Genotype | Immunophenotyping | In Situ Hybridization, Fluorescence | Carcinoma - chemistry | Breast Neoplasms - chemistry | Phenotype | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Oncogene Proteins, Fusion - genetics | Adult | Carcinoma - genetics | Female | Biomarkers, Tumor - genetics | Carcinoma - classification | Carcinoma - pathology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Clinicopathological characteristics and outcome of 31 patients with ETV6-NTRK3 fusion gene confirmed (mammary analogue) secretory carcinoma of salivary glands
by Boon, E and Valstar, M.H and van der Graaf, W.T.A and Bloemena, E and Willems, S.M and Meeuwis, C.A and Slootweg, P.J and Smit, L.A and Merkx, M.A.W and Takes, R.P and Kaanders, J.H.A.M and Groenen, P.J.T.A and Flucke, U.E and van Herpen, C.M.L
Oral Oncology, ISSN 1368-8375, 07/2018, Volume 82, pp. 29 - 33
In 2010, a new subtype of salivary gland cancer (SGC), (mammary analogue) secretory carcinoma (SC), was defined, characterized by the fusion gene. As clinical... 
Mammary analogue secretory carcinoma | Prognosis | Salivary gland neoplasms | ETV6-NTRK3 | MASC | Gene Fusion | Secretory carcinoma | Head and Neck Neoplasms | HEAD | CANCER | ONCOLOGY | DENTISTRY, ORAL SURGERY & MEDICINE | NECK | Carcinoma | Patient outcomes | Oncology, Experimental | Genes | Genetic research | Breast cancer | Genetic aspects | Research | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report
by Takahashi, Akimasa and Kurosawa, Manabu and Uemura, Mao and Kitazawa, Jun and Hayashi, Yoshihiko
Journal of International Medical Research, ISSN 0300-0605, 8/2018, Volume 46, Issue 8, pp. 3498 - 3503
Inflammatory myofibroblastic tumors (IMTs) are neoplasms with low malignant potential, and the most common tumor in the lung and orbit. Their occurrence in the... 
fluorescence in situ hybridization | crizotinib | uterus | anaplastic lymphoma kinase | ETV6–NTRK3 fusion gene | Inflammatory myofibroblastic tumor | ALK | MEDICINE, RESEARCH & EXPERIMENTAL | ETV6-NTRK3 fusion gene | REARRANGEMENTS | LINK | PHARMACOLOGY & PHARMACY | LEUKEMIA | EXPRESSION | Immunohistochemistry | Uterine Neoplasms - genetics | Oncogene Proteins, Fusion - metabolism | Humans | Neoplasms, Muscle Tissue - diagnosis | Anaplastic Lymphoma Kinase - genetics | Neoplasms, Muscle Tissue - genetics | Uterine Neoplasms - surgery | Oncogene Proteins, Fusion - genetics | Neoplasms, Muscle Tissue - surgery | Adult | Anaplastic Lymphoma Kinase - metabolism | Female | Uterine Neoplasms - diagnosis | Case Reports
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Novel gene fusions in secretory carcinoma of the salivary glands: enlarging the ETV6 family
by Guilmette, Julie and Dias-Santagata, Dora and Nosé, Vânia and Lennerz, Jochen K and Sadow, Peter M
Human Pathology, ISSN 0046-8177, 01/2019, Volume 83, pp. 50 - 58
Secretory carcinoma (SC) of the salivary gland is a low-grade malignancy associated with a well-defined clinical, histologic, immunohistochemical, and... 
ETV6-RET | Salivary gland tumor | Secretory carcinoma | MAML3 | ETV6-NTRK3 | ALIGNMENT | DUCT CARCINOMA | MIXED-PHENOTYPE | BIPHENOTYPIC SINONASAL SARCOMA | PATHOLOGY | INTRADUCTAL CARCINOMA | IMMUNOHISTOCHEMISTRY | Medical colleges | Anopheles | Carcinoma | RNA | Genes | Genetic research | Genetic aspects | Cancer | Automation | Hybridization | Morphology | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text The landscape of kinase fusions in cancer
by Stransky, Nicolas and Cerami, Ethan and Schalm, Stefanie and Kim, Joseph L and Lengauer, Christoph
Nature Communications, ISSN 2041-1723, 09/2014, Volume 5, Issue 1, p. 4846
Human cancer genomes harbour a variety of alterations leading to the deregulation of key pathways in tumour cells. The genomic characterization of tumours has... 
ALK | RET | REARRANGEMENT | TRANSCRIPTS | PATHWAY | MULTIDISCIPLINARY SCIENCES | ETV6-NTRK3 GENE FUSION | MUTATIONS | IDENTIFICATION | EXPRESSION | DEFINE | Gene Fusion - genetics | Sequence Analysis, RNA | Neoplasms - genetics | Humans | Gene Expression Profiling | Genome, Human | Molecular Targeted Therapy | Phosphotransferases - genetics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
by Drilon, Alexander and Laetsch, Theodore W and Kummar, Shivaani and DuBois, Steven G and Lassen, Ulrik N and Demetri, George D and Nathenson, Michael and Doebele, Robert C and Farago, Anna F and Pappo, Alberto S and Turpin, Brian and Dowlati, Afshin and Brose, Marcia S and Mascarenhas, Leo and Federman, Noah and Berlin, Jordan and El-Deiry, Wafik S and Baik, Christina and Deeken, John and Boni, Valentina and Nagasubramanian, Ramamoorthy and Taylor, Matthew and Rudzinski, Erin R and Meric-Bernstam, Funda and Sohal, Davendra P.S and Ma, Patrick C and Raez, Luis E and Hechtman, Jaclyn F and Benayed, Ryma and Ladanyi, Marc and Tuch, Brian B and Ebata, Kevin and Cruickshank, Scott and Ku, Nora C and Cox, Michael C and Hawkins, Douglas S and Hong, David S and Hyman, David M
The New England Journal of Medicine, ISSN 0028-4793, 02/2018, Volume 378, Issue 8, pp. 731 - 739
Fusions involving tropomyosin receptor genes are noted in cancers affecting children and adults. The TRK inhibitor larotrectinib induced a response in 75% of... 
CELL LUNG-CANCER | ACQUIRED-RESISTANCE | MEDICINE, GENERAL & INTERNAL | SOLID TUMORS | CARCINOMA | ETV6-NTRK3 GENE FUSION | Protein Kinases - genetics | Pyrazoles - therapeutic use | Protein Kinases - analysis | Humans | Middle Aged | Kaplan-Meier Estimate | Child, Preschool | Infant | Male | Antineoplastic Agents - therapeutic use | Neoplasms - drug therapy | Oncogene Proteins, Fusion - analysis | Young Adult | Disease-Free Survival | Neoplasms - chemistry | Pyrimidines - therapeutic use | Adolescent | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Aged | Child | Antimitotic agents | Treatment outcome | Safety and security measures | Analysis | Dosage and administration | Diagnosis | Antineoplastic agents | Cancer | Medical research | Inhibitor drugs | Tropomyosin | Oncology | Survival | Patients | Cancer therapies | Children & youth | Antitumor activity | Children | Drug dosages | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines
by Ha, Kevin C.H and Lalonde, Emilie and Li, Lili and Cavallone, Luca and Natrajan, Rachael and Lambros, Maryou B and Mitsopoulos, Costas and Hakas, Jarle and Kozarewa, Iwanka and Fenwick, Kerry and Lord, Chris J and Ashworth, Alan and Vincent-Salomon, Anne and Basik, Mark and Reis-Filho, Jorge S and Majewski, Jacek and Foulkes, William D
BMC Medical Genomics, ISSN 1755-8794, 2011, Volume 4, Issue 1, pp. 75 - 75
Background: Gene fusions arising from chromosomal translocations have been implicated in cancer. However, the role of gene fusions in BRCA1-related breast... 
METHYLTHIOADENOSINE PHOSPHORYLASE | ETV6-NTRK3 | RNA-SEQ | TRANSLOCATIONS | GENETICS & HEREDITY | HOMOLOGOUS RECOMBINATION | BRCA1 | PRIMARY EVENT | EXPRESSION | CARCINOMA | TOOL | Chromosome Breakpoints | Humans | RNA, Messenger - genetics | Molecular Sequence Data | Gene Expression Profiling - methods | DNA Copy Number Variations - genetics | Feasibility Studies | Sequence Analysis, RNA - methods | BRCA1 Protein - genetics | Gene Fusion - genetics | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Base Sequence | Cell Line, Tumor | Female | Mutation | High-Throughput Nucleotide Sequencing - methods | Polymerase chain reaction | Usage | Gene mutations | Development and progression | Breast cancer | Genetic aspects | Research | Studies | Proteins | Medical research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Antitumor activity of larotrectinib in tumors harboring NTRK gene fusions: a short review on the current evidence
by Ricciuti, B and Genova, C and Crino, L and Libra, M and Leonardi, GC
ONCOTARGETS AND THERAPY, ISSN 1178-6930, 2019, Volume 12, pp. 3171 - 3179
The development of deep-sequencing methods is now unveiling a new landscape of previously undetected gene fusion across different tumor types. Chromosomal... 
RET | TRANSFORMATION | larotrectinib | PAN-TRK | ETV6-NTRK3 | INHIBITOR ENTRECTINIB | KINASE | ACQUIRED-RESISTANCE | REARRANGEMENTS | resistance | ONCOGENE | chromosomal rearrangements | ONCOLOGY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | NTRK | CARCINOMA | Clinical trials | FDA approval | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text High-throughput detection of fusion genes in cancer using the Sequenom MassARRAY platform
by Lambros, Maryou B.K and Wilkerson, Paul M and Natrajan, Rachael and Patani, Neill and Pawar, Vidya and Vatcheva, Radost and Mansour, Marthe and Laschet, Mirja and Oelze, Beatrice and Orr, Nicholas and Muller, Susanne and Reis-Filho, Jorge S
Laboratory Investigation, ISSN 0023-6837, 10/2011, Volume 91, Issue 10, pp. 1491 - 1501
Fusion genes have pivotal roles in the development and progression of human cancer and offer potential for rational drug design. Massively parallel sequencing... 
breast cancer | genetics | fusion gene | MassARRAY | high-throughput | Sequenom | MEDICINE, RESEARCH & EXPERIMENTAL | ETV6-NTRK3 | TYROSINE KINASE | PATHOLOGY | TOF MASS-SPECTROMETRY | REARRANGEMENTS | SECRETORY BREAST-CARCINOMA | ADENOID CYSTIC CARCINOMAS | PROSTATE-CANCER | RECURRENT FUSION | TRANSCRIPTION FACTOR GENES | PRIMARY EVENT | Microarray Analysis - methods | Genetic Testing - standards | Humans | In Situ Hybridization, Fluorescence | Reverse Transcriptase Polymerase Chain Reaction | High-Throughput Nucleotide Sequencing - standards | Oncogene Proteins, Fusion | Breast Neoplasms - genetics | Sensitivity and Specificity | Cell Line, Tumor | Female | Microarray Analysis - standards | HeLa Cells | High-Throughput Nucleotide Sequencing - methods
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Secretory carcinoma - Impact of translocation and gene fusions on salivary gland tumor
by Inaki, Ryoko and Abe, Masanobu and Zong, Liang and Abe, Takahiro and Shinozaki-Ushiku, Aya and Ushiku, Tetsuo and Hoshi, Kazuto and Graduate School of Medicine, University of Tokyo, Tokyo 113-8654, Japan and Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Surgery, Peking University Cancer Hospital & Institute, Beijing 100142, China and Division for Health Service Promotion, University of Tokyo, Tokyo 113-003, Japan and Department of Pathology, Graduate School of Medicine, University of Tokyo, Tokyo 113-8655, Japan and Department of Oral & Maxillofacial Surgery, University of Tokyo Hospital, Tokyo 113-8655, Japan
Chinese Journal of Cancer Research, ISSN 1000-9604, 10/2017, Volume 29, Issue 5, pp. 379 - 384
Secretory carcinoma (SC), previously described as mammary analogue secretory carcinoma (MASC), is a recently described salivary gland tumor which... 
Mammary analogue secretory carcinoma | Salivary gland tumor | ETV6-NTRK3 fusion gene | Secretory carcinoma | MASC | ACINIC CELL CARCINOMAS | RECENTLY DESCRIBED ENTITY | TYROSINE KINASE | mammary analogue secretory carcinoma | CONGENITAL FIBROSARCOMA | PATHOLOGY | salivary gland tumor | IMMUNOHISTOCHEMICAL SPECTRUM | BREAST | FEATURES | ORIGIN | ONCOLOGY | UPDATE | Review
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text A case of estrogen receptor positive secretory carcinoma in a 9-year-old girl with ETV6-NTRK3 fusion gene
by Yorozuya, Kyoko and Takahashi, Emiko and Kousaka, Junko and Mouri, Yukako and Yoshida, Miwa and Fujii, Kimihito and Akizuki, Miwa and Nakano, Shogo and Fukutomi, Takashi and Umemoto, Yasutaka and Yokoi, Toyoharu and Imai, Hiroshi
Japanese Journal of Clinical Oncology, ISSN 0368-2811, 03/2012, Volume 42, Issue 3, pp. 208 - 211
The patient was a 9-year-old premenarcheal pediatric female, whose chief complaint was a well-circumscribed palpable right breast mass without nipple... 
Basal marker | Estrogen receptor | ETV6-NTRK3 fusion gene | Juvenile breast cancer | Secretory carcinoma | Immunohistochemistry | Receptors, Estrogen - genetics | Humans | Reverse Transcriptase Polymerase Chain Reaction | Breast Neoplasms - metabolism | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Oncogene Proteins, Fusion - genetics | Receptors, Estrogen - biosynthesis | Carcinoma - genetics | Female | Carcinoma - metabolism | Carcinoma - pathology | Child
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights